e-learning
resources
Vienna 2012
Monday, 03.09.2012
Trials in COPD: novel treatments and insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy
M. Small, S. Broomfield, V. Higgins (Macclesfield, United Kingdom)
Source:
Annual Congress 2012 - Trials in COPD: novel treatments and insights
Session:
Trials in COPD: novel treatments and insights
Session type:
Poster Discussion
Number:
2876
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Small, S. Broomfield, V. Higgins (Macclesfield, United Kingdom). Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy. Eur Respir J 2012; 40: Suppl. 56, 2876
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results
Source: Eur Respir J 2005; 26: Suppl. 49, 69s
Year: 2005
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
Source: Eur Respir J 2013; 42: 1391-1401
Year: 2013
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Different methods to classify COPD patients into the ABCD severity groups – Preliminary results of the LQ-DMP project
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
The distribution of COPD in general practice using three different GOLD classification
Source: International Congress 2018 – COPD around the world
Year: 2018
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Stability of the exacerbation pattern defined by GOLD 2017 in a real-world COPD population
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Distribution of a COPD population based on the GOLD assessment framework
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Prediction of the clinical course of COPD using the old and the new GOLD classification
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines
Source: Eur Respir J 2016; 47: 978-980
Year: 2016
Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?
Source: Eur Respir J 2014; 43: 1201-1203
Year: 2014
Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification
Source: Eur Respir J 2013; 42: 647-654
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept